chr10-26217930-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_001134366.2(GAD2):c.225C>T(p.Cys75Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,611,790 control chromosomes in the GnomAD database, including 36 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0030 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 30 hom. )
Consequence
GAD2
NM_001134366.2 synonymous
NM_001134366.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.778
Genes affected
GAD2 (HGNC:4093): (glutamate decarboxylase 2) This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Oct 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 10-26217930-C-T is Benign according to our data. Variant chr10-26217930-C-T is described in ClinVar as [Benign]. Clinvar id is 771432.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.778 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00299 (455/152316) while in subpopulation AMR AF= 0.0198 (303/15310). AF 95% confidence interval is 0.018. There are 6 homozygotes in gnomad4. There are 239 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 455 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAD2 | ENST00000376261.8 | c.225C>T | p.Cys75Cys | synonymous_variant | Exon 3 of 16 | 1 | NM_001134366.2 | ENSP00000365437.3 | ||
GAD2 | ENST00000259271.7 | c.225C>T | p.Cys75Cys | synonymous_variant | Exon 3 of 17 | 1 | ENSP00000259271.3 | |||
GAD2 | ENST00000428517.2 | n.225C>T | non_coding_transcript_exon_variant | Exon 3 of 4 | 1 | ENSP00000390434.2 | ||||
GAD2 | ENST00000648567 | c.-118C>T | 5_prime_UTR_variant | Exon 3 of 17 | ENSP00000498009.1 |
Frequencies
GnomAD3 genomes AF: 0.00297 AC: 452AN: 152198Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
452
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00566 AC: 1382AN: 244332Hom.: 21 AF XY: 0.00432 AC XY: 576AN XY: 133320
GnomAD3 exomes
AF:
AC:
1382
AN:
244332
Hom.:
AF XY:
AC XY:
576
AN XY:
133320
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00156 AC: 2280AN: 1459474Hom.: 30 Cov.: 32 AF XY: 0.00146 AC XY: 1057AN XY: 725980
GnomAD4 exome
AF:
AC:
2280
AN:
1459474
Hom.:
Cov.:
32
AF XY:
AC XY:
1057
AN XY:
725980
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00299 AC: 455AN: 152316Hom.: 6 Cov.: 32 AF XY: 0.00321 AC XY: 239AN XY: 74478
GnomAD4 genome
AF:
AC:
455
AN:
152316
Hom.:
Cov.:
32
AF XY:
AC XY:
239
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3474
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
May 18, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at